The following discussion and analysis of the company's financial condition and
results of operations should be read in conjunction with our audited financial
statements and the notes related thereto which are included in "Item 8.
Financial Statements and Supplementary Data" of this Amendment. Certain
information contained in the discussion and analysis set forth below includes
forward-looking statements. Our actual results may differ materially from those
anticipated in these forward-looking statements as a result of many factors,
including those set forth under "Item 1A. Risk Factors" in the Original Filing
and "Cautionary Note Regarding Forward-Looking Statements and Risk Factor
Summary" and elsewhere in this Amendment.
This Management's Discussion and Analysis of Financial Condition and Results of
Operations has been amended and restated to give effect to the restatement and
revision of our financial statements as more fully described in the Explanatory
Note and in "Note 2-Restatement of Previously Issued Financial Statements" to
our accompanying financial statements. For further detail regarding the
restatement adjustments, see Explanatory Note and Item 9A: Controls and
Procedures, both contained herein.
Overview
We are a blank check company incorporated on July 28, 2020 as a Cayman Islands
exempted company for the purpose of effecting a merger, share exchange, asset
acquisition, share purchase, reorganization or similar business combination with
one or more businesses or entities. We intend to effectuate our initial business
combination using cash from the proceeds of our initial public offering and the
sale of the private placement warrants, our shares, debt or a combination of
cash, equity and debt.
We expect to continue to incur significant costs in the pursuit of our
acquisition plans. We cannot assure you that our plans to complete a business
combination will be successful.
Recent Developments
On March 1, 2021, we entered into an Agreement and Plan of Merger with Rocket
Lab, and Prestige USA Merger Sub, Inc., a Delaware corporation and a wholly
owned subsidiary of Rocket Lab. The Merger Agreement and the transactions
contemplated thereby were unanimously approved by the boards of directors of
each of the Company and Rocket Lab.
In contemplation of the Business Combination, we will domesticate as a Delaware
corporation (the "Domestication" and the company following the Domestication,
"Delaware Vector") and, in connection therewith, (a) the Class A ordinary shares
and the Class B ordinary shares issued and outstanding immediately prior to the
Domestication will convert into an equal number of shares of common stock, par
value $0.0001 per share, of Vector Delaware (the "Delaware Vector Common
Stock"); (b) our warrants to purchase Class A ordinary shares issued and
outstanding immediately prior to the Domestication will convert into an equal
number of warrants to purchase Delaware Vector Common Stock (the "Delaware
Vector Warrants") and (c) our units that have not been separated into Class A
ordinary shares and warrants issued and outstanding immediately prior to the
Domestication will convert into an equal number of units of Delaware Vector
(the "Delaware Vector Units").
Immediately following the Domestication, Merger Sub will merge with and into
Delaware Vector, with Delaware Vector surviving the merger as a wholly owned
subsidiary of Rocket Lab (the "First Merger"), and in connection therewith,
(a) the shares of Delaware Vector Common Stock (other than any treasury shares,
shares held by Delaware Vector or any dissenting shares) issued and outstanding
immediately prior to the effective time of the First Merger (the "First
Effective Time") will convert into an equal number of shares of Rocket Lab
Common Stock; (b) the Delaware Vector Warrants that are outstanding and
unexercised immediately prior to the First Effective Time will convert into an
equal number of warrants to purchase Rocket Lab Common Stock (the "Assumed
Warrants") and (c) the Delaware Vector Units that are outstanding immediately
prior to the First Effective Time will convert into an equal number of units of
Rocket Lab (the "Assumed Units"); and immediately following the First Effective
Time, Rocket Lab will merge with and into Delaware Vector, with Delaware Vector
surviving the merger (Delaware Vector as the surviving corporation, "PublicCo"
and such merger, the "Second Merger" and, together with the First Merger, the
"Mergers"). If the closing price of PublicCo Common Stock is equal to or greater
than $20.00 for a period of at least 20 days out of 30 consecutive trading days
during the period commencing on the 90th day following the closing of the
Business Combination (the "Closing") and ending on the 180th day following the
Closing, the Rocket Lab stockholders will be entitled to receive additional
shares of PublicCo Common Stock equal to 8% of the Aggregate Share
Consideration.
For purposes of the Merger Agreement, the "Exchange Ratio" equals the quotient
obtained by dividing (i) the Aggregate Share Consideration by (ii) the aggregate
number of shares of Rocket Lab Common Stock outstanding immediately prior to the
Charter Amendment on a fully diluted basis (other than the Management Redemption
Shares). The "Aggregate Share Consideration" means the quotient obtained by
dividing (i) an amount equal to $4,000,000,000 minus the Management Redemption
Amount by (ii) (x) an amount equal to $10.00 plus (y) an amount equal to (a) the
interest earned on funds held in Vector's trust account divided by (b) the
number of Class A ordinary shares outstanding immediately prior to the Closing.
The Domestication, the Mergers and the other transactions contemplated by the
Agreement are hereinafter referred to as the "Business Combination". The
Business Combination is expected to close in the second quarter of 2021, subject
to the satisfaction of certain customary closing conditions.
3
Concurrently with the execution of the Agreement, we entered into subscription
agreements (the "Subscription Agreements") with certain investors (the "PIPE
Investors"), pursuant to which the PIPE Investors agreed to subscribe for and
purchase, and the company agreed to issue and sell to such PIPE Investors,
immediately prior to Closing, an aggregate of 46,700,000 shares of PublicCo
Common Stock for a purchase price of $10.00 per share, for aggregate gross
proceeds of $467,000,000 (the "PIPE Financing").
The closing of the PIPE Financing is contingent upon, among other things, the
substantially concurrent consummation of the Business Combination. The
Subscription Agreements provide that the company will grant the investors in the
PIPE Financing certain customary registration rights.
Results of Operations
We have neither engaged in any operations nor generated any revenues to date.
Our only activities from inception to December 31, 2020 were organizational
activities, those necessary to prepare for the initial public offering,
described below, and, after the initial public offering, identifying a target
company for a business combination. We do not expect to generate any operating
revenues until after the completion of our business combination. We generate
non-operating income in the form of interest income on marketable securities
held in the trust account. We incur expenses as a result of being a public
company (for legal, financial reporting, accounting and auditing compliance), as
well as for due diligence expenses in connection with completing a business
combination.
As a result of the restatement described in Note 2 of the notes to the financial
statements included herein, we classify the warrants issued in connection with
our Initial Public Offering as liabilities at their fair value and adjust the
warrant instrument to fair value at each reporting period. This liability is
subject to re-measurement at each balance sheet date until exercised, and any
change in fair value is recognized in our statement of operations.
For the period from July 28, 2020 (inception) through December 31, 2020, we had
a net loss of $12,341,951, which consisted of formation and operating expenses
of $357,463 and a change in the fair value of the warrant liability of
$11,989,334 offset by interest earned on investment held in the trust account of
$4,846.
Liquidity and Capital Resources
On September 29, 2020, we consummated the initial public offering of 30,000,000
units, at a price of $10.00 per unit, generating gross proceeds of $300,000,000.
Simultaneously with the closing of our initial public offering, we consummated
the sale of 5,333,333 private placement warrants to our sponsor at a price of
$1.50 per private placement warrant generating gross proceeds of $8,000,000.
On October 20, 2020, in connection with the underwriters' election to partially
exercise their over-allotment option, we consummated the sale of an additional
2,000,000 units and the sale of an additional 266,667 private placement
warrants, generating total gross proceeds of $20,400,000.
Following our initial public offering, the partial exercise of the
over-allotment option and the sale of the private placement warrants, a total of
$320,000,000 was placed in the trust account. We incurred $18,252,382 in
transaction costs, including $6,400,000 of underwriting fees, $11,200,000 of
deferred underwriting fees and $652,382 of other offering costs.
For the period from July 28, 2020 (inception) through December 31, 2020, net
cash used in operating activities was $506,715, which consisted of our net loss
of $12,341,951 affected by interest earned on investment held in the trust
account of $4,846, a non-cash charge for the change in the fair value of warrant
liabilities of $11,989,334 and changes in operating assets and liabilities,
which used $149,252 of cash from operating activities.
As of December 31, 2020, we had investments held in the trust account of
$320,004,846. We intend to use substantially all of the funds held in the Trust
Account, including any amounts representing interest earned on the trust
account, which interest shall be net of taxes payable and excluding deferred
underwriting commissions, to complete our business combination. We may withdraw
interest from the trust account to pay taxes, if any. To the extent that our
share capital or debt is used, in whole or in part, as consideration to complete
a business combination, the remaining proceeds held in the trust account will be
used as working capital to finance the operations of the target business or
businesses, make other acquisitions and pursue our growth strategies.
At December 31, 2020, we had cash of $865,903 held outside of the trust account.
We intend to use the funds held outside the trust account primarily to identify
and evaluate target businesses, perform business due diligence on prospective
target businesses, travel to and from the offices, plants or similar locations
of prospective target businesses or their representatives or owners, review
corporate documents and material agreements of prospective target businesses,
structure, negotiate and complete a business combination.
In order to fund working capital deficiencies or finance transaction costs in
connection with a business combination, our sponsor or an affiliate of our
sponsor or certain of our officers and directors may, but are not obligated to,
loan us funds as may be required. If we complete a business combination, we may
repay such loaned amounts out of the proceeds of the trust account released to
us. In the event that a business combination does not close, we may use a
portion of the working capital held outside the trust account to repay such
loaned amounts, but no proceeds from our trust account would be used for such
repayment. Up to $1,500,000 of such loans may be convertible into warrants, at a
price of $1.00 per warrant, at the option of the lender. The warrants would be
identical to the private placement warrants.
4
We do not believe we will need to raise additional funds in order to meet the
expenditures required for operating our business. However, if our estimate of
the costs of identifying a target business, undertaking in-depth due diligence
and negotiating a business combination are less than the actual amount necessary
to do so, we may have insufficient funds available to operate our business prior
to our initial business combination. Moreover, we may need to obtain additional
financing either to complete our business combination or because we become
obligated to redeem a significant number of our public shares upon completion of
our business combination, in which case we may issue additional securities or
incur debt in connection with such business combination.
Off-Balance Sheet Financing Arrangements
We have no obligations, assets or liabilities, which would be considered
off-balance sheet arrangements as of December 31, 2020. We do not participate in
transactions that create relationships with unconsolidated entities or financial
partnerships, often referred to as variable interest entities, which would have
been established for the purpose of facilitating off-balance sheet arrangements.
We have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or commitments of
other entities, or purchased any non-financial assets.
Contractual Obligations
We do not have any long-term debt, capital lease obligations, operating lease
obligations or long-term liabilities, other than an agreement to pay our sponsor
a monthly fee of $10,000 for office space, administrative and support services,
provided to the company. We began incurring these fees on September 24, 2020 and
will continue to incur these fees monthly until the earlier of the completion of
a business combination or the company's liquidation.
The underwriters are entitled to a deferred fee of $0.35 per Unit, or
$11,200,000 in the aggregate. The deferred fee will become payable to the
underwriters from the amounts held in the trust account solely in the event that
we complete a business combination, subject to the terms of the underwriting
agreement.
Critical Accounting Policies
The preparation of financial statements and related disclosures in conformity
with accounting principles generally accepted in the United States of America
requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities, disclosure of contingent assets and
liabilities at the date of the financial statements, and income and expenses
during the periods reported. Actual results could materially differ from those
estimates. We have identified the following critical accounting policies:
Warrant Liability
We account for the warrants issued in connection with our initial public
offering in accordance with the guidance contained in ASC 815-40 under which the
warrants do not meet the criteria for equity treatment and must be recorded as
liabilities. Accordingly, we classify the warrants as liabilities at their fair
value and adjust the warrants to fair value at each reporting period. This
liability is subject to re-measurement at each balance sheet date until
exercised, and any change in fair value is recognized in our statement of
operations. The initial fair value of the warrants was estimated using a Monte
Carlo simulation approach.
Class A Ordinary Shares Subject to Possible Redemption
We account for our Class A ordinary shares subject to possible redemption in
accordance with the guidance in Accounting Standards Codification ("ASC") Topic
480 "Distinguishing Liabilities from Equity." Class A Ordinary shares subject to
mandatory redemption is classified as a liability instrument and is measured at
fair value. Conditionally redeemable ordinary shares (including ordinary shares
that features redemption rights that is either within the control of the holder
or subject to redemption upon the occurrence of uncertain events not solely
within our control) is classified as temporary equity. At all other times,
ordinary shares are classified as shareholders' equity. Our Class A ordinary
shares feature certain redemption rights that are considered to be outside of
our control and subject to occurrence of uncertain future events. Accordingly,
Class A ordinary shares subject to possible redemption is presented as temporary
equity, outside of the shareholders' equity section of our balance sheet.
Net Income (Loss) per Ordinary Share
We apply the two-class method in calculating earnings per share. Net income per
ordinary share, basic and diluted for Class A redeemable ordinary shares is
calculated by dividing the interest income earned on the trust account by the
weighted average number of Class A redeemable ordinary shares outstanding since
original issuance. Net loss per ordinary share, basic and diluted for Class B
non-redeemable ordinary shares is calculated by dividing the net income (loss),
less income attributable to Class A redeemable ordinary shares, by the weighted
average number of Class B non-redeemable ordinary shares outstanding for the
periods presented.
Recent Accounting Standards
Management does not believe that any other recently issued, but not yet
effective, accounting standards, if currently adopted, would have a material
effect on our financial statements.
5
© Edgar Online, source Glimpses